188 related articles for article (PubMed ID: 25903659)
1. Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.
Talbot HK; Coleman LA; Zhu Y; Spencer S; Thompson M; Cheng PY; Sundaram ME; Belongia EA; Griffin MR
BMC Infect Dis; 2015 Apr; 15():195. PubMed ID: 25903659
[TBL] [Abstract][Full Text] [Related]
2. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
Front Immunol; 2018; 9():2465. PubMed ID: 30405641
[No Abstract] [Full Text] [Related]
3. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old.
Sundaram ME; Talbot HK; Zhu Y; Griffin MR; Spencer S; Shay DK; Coleman LA
Vaccine; 2013 Apr; 31(16):2057-61. PubMed ID: 23453766
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
Kositanont U; Assantachai P; Wasi C; Puthavathana P; Praditsuwan R
Viral Immunol; 2012 Dec; 25(6):471-6. PubMed ID: 23061793
[TBL] [Abstract][Full Text] [Related]
7. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.
Lin SY; Wu ET; Lin CH; Shyu MK; Lee CN
PLoS One; 2013; 8(6):e62983. PubMed ID: 23762229
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
Williams KV; Moehling Geffel K; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Susick M; Zimmerman RK
Vaccine; 2023 Jan; 41(3):862-869. PubMed ID: 36543682
[TBL] [Abstract][Full Text] [Related]
9. Effects of Banafine
Horie K; Hossain MS; Kim Y; Akiko I; Kon R; Yamatsu A; Kishima M; Nishikimi T; Kim M
J Food Sci; 2021 Apr; 86(4):1410-1417. PubMed ID: 33768522
[TBL] [Abstract][Full Text] [Related]
10. Are plasma mineral levels related to antibody response to influenza vaccination in older adults?
Kaynar AM; Nowalk MP; Lin CJ; Moehling KK; Susick M; Bakalov V; Pitt BR; Bain DJ; Ross TM; Saul SG; Raymund M; Zimmerman RK
Hum Vaccin Immunother; 2016 Apr; 12(4):1003-8. PubMed ID: 26751915
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
Ganczak M; Dubiel P; Drozd-Dąbrowska M; Hallmann-Szelińska E; Szymański K; Brydak LB
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31739554
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
Petrie JG; Martin ET; Truscon R; Johnson E; Cheng CK; McSpadden EJ; Malosh RE; Lauring AS; Lamerato LE; Eichelberger MC; Ferdinands JM; Monto AS
Vaccine; 2019 Feb; 37(10):1284-1292. PubMed ID: 30738647
[TBL] [Abstract][Full Text] [Related]
13. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Stukova M; Buzitskaya Z; Кulmagambetov I; Davlyatshin T; Khairullin B
Hum Vaccin Immunother; 2018 Mar; 14(3):609-614. PubMed ID: 29112488
[TBL] [Abstract][Full Text] [Related]
15. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.
McLean HQ; King JP; Talley P; Flannery B; Spencer S; Levine MZ; Friedrich TC; Belongia EA
J Pediatric Infect Dis Soc; 2020 Apr; 9(2):173-180. PubMed ID: 30759228
[TBL] [Abstract][Full Text] [Related]
16. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.
Talbot HK; Coleman LA; Crimin K; Zhu Y; Rock MT; Meece J; Shay DK; Belongia EA; Griffin MR
Vaccine; 2012 Jun; 30(26):3937-3943. PubMed ID: 22484350
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
Nakphook S; Patumanond J; Shrestha M; Prasert K; Chittaganpitch M; Mott JA; Praphasiri P
PLoS One; 2021; 16(6):e0253028. PubMed ID: 34106994
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
19. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
[TBL] [Abstract][Full Text] [Related]
20. Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status.
Zhong S; Ng TWY; Skowronski DM; Iuliano AD; Leung NHL; Perera RAPM; Ho F; Fang VJ; Tam YH; Ip DKM; Havers FG; Fry AM; Aziz-Baumgartner E; Barr IG; Peiris M; Thompson MG; Cowling BJ
J Infect Dis; 2024 May; 229(5):1451-1459. PubMed ID: 37950884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
